RE:RE:RE:RE:RE:RE:On the positive side The positives are increasing sales, enrolment is ongoing and they are "lazer focused" on it, previous and future planned interactions with institutions, ongoing partnership discussions for both oncology and NASH, looking for experts interacting with the agencies etc.
As for expectations from this board they are very high due to the fact most of us been patiently waiting for a long time so we want exceptional results yesterday.
Imagine despite all odds the company starting marketing itself and its prospects to much broader audiences adding new investors who are not as impatient as we are. Would today's CC comes across as negative as it did to some of us compared to the new investors? In my opinion they are now operating the company as they should and quite frankly they couldn't do much more than they have but again this company needs new investors the issue is the company believes they can attract those investors only through institutional engagements which is maddening wrong.
Correct me if I am wrong even if their point is valid why having rules stopping the shared information with institutional investors from getting passed to their clients? It just doesn't make sense at all.